TY - JOUR
T1 - Exploring the possible binding sites at the interface of triosephosphate isomerase dimer as a potential target for anti-tripanosomal drug design
AU - Espinoza-Fonseca, L. Michel
AU - Trujillo-Ferrara, José G.
N1 - Funding Information:
We thank Drs. Armando Gómez-Puyou, Ruy Pérez-Montfort and Arturo Rojo-Dominguez for fruitful discussions about this work. This work was supported under CONACYT and CGPI-IPN grants 31935 and 200860.
PY - 2004/6/21
Y1 - 2004/6/21
N2 - To explore the possible binding sites at the interface of tripanosomal triosephosphate isomerase, fully flexible benzothiazoles were docked onto the dimer interface. Docking studies revealed that the most favorable interactions occur in the aromatic clusters of the dimeric form. Hence is purposed that the dimer disruption is not via Cys 15, as presented in last studies, but it could be carried out through the unstabilization of π-π interactions of two aromatic clusters present in the interface. These studies enable a novel alternative for rational structure-based anti-tripanosomal drug design.
AB - To explore the possible binding sites at the interface of tripanosomal triosephosphate isomerase, fully flexible benzothiazoles were docked onto the dimer interface. Docking studies revealed that the most favorable interactions occur in the aromatic clusters of the dimeric form. Hence is purposed that the dimer disruption is not via Cys 15, as presented in last studies, but it could be carried out through the unstabilization of π-π interactions of two aromatic clusters present in the interface. These studies enable a novel alternative for rational structure-based anti-tripanosomal drug design.
UR - http://www.scopus.com/inward/record.url?scp=2442545256&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=2442545256&partnerID=8YFLogxK
U2 - 10.1016/j.bmcl.2004.04.013
DO - 10.1016/j.bmcl.2004.04.013
M3 - Article
C2 - 15149664
AN - SCOPUS:2442545256
VL - 14
SP - 3151
EP - 3154
JO - Bioorganic and Medicinal Chemistry Letters
JF - Bioorganic and Medicinal Chemistry Letters
SN - 0960-894X
IS - 12
ER -